Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phase 2b randomized trials in adolescents
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phase 2b randomized trials in adolescents
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 17, Issue 11, Pages 4689-4700
Publisher
Informa UK Limited
Online
2021-09-29
DOI
10.1080/21645515.2021.1968214
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy
- (2021) Cecilia Fazio et al. Human Vaccines & Immunotherapeutics
- Synergic complement‐mediated bactericidal activity of monoclonal antibodies with distinct specificity
- (2020) Eriberto Noel Natali et al. FASEB JOURNAL
- First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England
- (2020) Shamez N Ladhani et al. CLINICAL INFECTIOUS DISEASES
- Immune Responses to Booster Vaccination With Meningococcal ABCWY Vaccine After Primary Vaccination With Either Investigational or Licensed Vaccines
- (2018) Leszek Szenborn et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes
- (2018) M. Giuliani et al. Scientific Reports
- Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults
- (2018) Xavier Sáez-Llorens et al. Human Vaccines & Immunotherapeutics
- Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines
- (2018) Rodolfo Villena et al. Human Vaccines & Immunotherapeutics
- Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents – Results from a randomized, controlled, observer-blind phase II study
- (2018) Jo Anne Welsch et al. VACCINE
- Meningococcal serogroups and surveillance: a systematic review and survey
- (2018) Meagan E Peterson et al. Journal of Global Health
- An unwanted guest: Neisseria meningitidis – carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence
- (2017) Elena Gianchecchi et al. Expert Review of Anti-Infective Therapy
- Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study
- (2017) Helen Petousis-Harris et al. LANCET
- The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines
- (2016) Stephen I. Pelton JOURNAL OF ADOLESCENT HEALTH
- Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
- (2016) Sydel R Parikh et al. LANCET
- Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Meningococcal ACWY Conjugate Vaccine in Infants
- (2016) Stan L. Block et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Enter B and W: two new meningococcal vaccine programmes launched
- (2015) Shamez N Ladhani et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Persistence of Meningococcal Antibodies and Response to a Third Dose After a Two-dose Vaccination Series with Investigational MenABCWY Vaccine Formulations in Adolescents
- (2015) Xavier Saez-Llorens et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine and Commonly Administered Vaccines after Co-administration
- (2015) Roberto Gasparini et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety and immunogenicity of a four-component meningococcal group B vaccine (4CMenB) and a quadrivalent meningococcal group ACWY conjugate vaccine administered concomitantly in healthy laboratory workers
- (2015) Jamie Findlow et al. VACCINE
- Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study
- (2015) Kirsten P. Perrett et al. VACCINE
- A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial
- (2015) Stan L. Block et al. VACCINE
- Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents
- (2015) Xavier Saez-Llorens et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and safety of a quadrivalent meningococcal polysaccharide CRM conjugate vaccine in infants and toddlers
- (2014) Miguel Tregnaghi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- A phase II randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II)
- (2014) Susanna Esposito et al. Human Vaccines & Immunotherapeutics
- A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I)
- (2014) Roman Prymula et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials
- (2013) Timo Vesikari et al. LANCET
- Immunogenicity and safety of a CRM-conjugated meningococcal ACWY vaccine administered concomitantly with routine vaccines starting at 2 months of age
- (2013) Terry M Nolan et al. Human Vaccines & Immunotherapeutics
- Novel meningococcal 4CMenB vaccine antigens - prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae
- (2012) Ronza Hadad et al. APMIS
- Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules
- (2012) Nicoletta Gossger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
- (2012) Eva Hong et al. VACCINE
- Development of an Automated, High-Throughput Bactericidal Assay That Measures Cellular Respiration as a Survival Readout for Neisseria meningitidis
- (2011) Puiying A. Mak et al. Clinical and Vaccine Immunology
- Immunogenicity and Safety of a Multicomponent Meningococcal Serogroup B Vaccine and a Quadrivalent Meningococcal CRM197Conjugate Vaccine against Serogroups A, C, W-135, and Y in Adults Who Are at Increased Risk for Occupational Exposure to Meningococcal Isolates
- (2010) Alan Kimura et al. Clinical and Vaccine Immunology
- Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy
- (2010) Jamie Findlow et al. CLINICAL INFECTIOUS DISEASES
- Menveo®: a novel quadrivalent meningococcal CRM197conjugate vaccine against serogroups A, C, W-135 and Y
- (2010) Brian Cooper et al. Expert Review of Vaccines
- Meningococcal carriage by age: a systematic review and meta-analysis
- (2010) Hannah Christensen et al. LANCET INFECTIOUS DISEASES
- Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease
- (2009) Amanda C. Cohn et al. CLINICAL INFECTIOUS DISEASES
- Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlers
- (2009) S. A. Halperin et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now